chr4-23834777-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_013261.5(PPARGC1A):c.235-3026G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.638 in 151,904 control chromosomes in the GnomAD database, including 30,945 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.64 ( 30945 hom., cov: 31)
Consequence
PPARGC1A
NM_013261.5 intron
NM_013261.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.530
Publications
9 publications found
Genes affected
PPARGC1A (HGNC:9237): (PPARG coactivator 1 alpha) The protein encoded by this gene is a transcriptional coactivator that regulates the genes involved in energy metabolism. This protein interacts with PPARgamma, which permits the interaction of this protein with multiple transcription factors. This protein can interact with, and regulate the activities of, cAMP response element binding protein (CREB) and nuclear respiratory factors (NRFs). It provides a direct link between external physiological stimuli and the regulation of mitochondrial biogenesis, and is a major factor that regulates muscle fiber type determination. This protein may be also involved in controlling blood pressure, regulating cellular cholesterol homoeostasis, and the development of obesity. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.686 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPARGC1A | NM_013261.5 | c.235-3026G>A | intron_variant | Intron 2 of 12 | ENST00000264867.7 | NP_037393.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.638 AC: 96866AN: 151786Hom.: 30915 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
96866
AN:
151786
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.638 AC: 96949AN: 151904Hom.: 30945 Cov.: 31 AF XY: 0.637 AC XY: 47291AN XY: 74206 show subpopulations
GnomAD4 genome
AF:
AC:
96949
AN:
151904
Hom.:
Cov.:
31
AF XY:
AC XY:
47291
AN XY:
74206
show subpopulations
African (AFR)
AF:
AC:
25273
AN:
41414
American (AMR)
AF:
AC:
10653
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
2338
AN:
3466
East Asian (EAS)
AF:
AC:
2683
AN:
5160
South Asian (SAS)
AF:
AC:
2895
AN:
4814
European-Finnish (FIN)
AF:
AC:
6799
AN:
10514
Middle Eastern (MID)
AF:
AC:
202
AN:
294
European-Non Finnish (NFE)
AF:
AC:
44179
AN:
67940
Other (OTH)
AF:
AC:
1391
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1840
3679
5519
7358
9198
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
798
1596
2394
3192
3990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2138
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.